BIT 6.67% 3.2¢ biotron limited

Ann: BIOTRON CLINICAL TRIAL RESULTS WEBINAR, page-72

  1. 337 Posts.
    lightbulb Created with Sketch. 87

    Borrowing against future R&D grants through Rockinghorse and similar financiers is expensive.

    https://rockinghorsegroup.com.au/

    They also want security over the assets of the company. You know like that library of compounds and the IP we've paid for.

    If it was high risk before, its even higher risk now.
 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
(20min delay)
Last
3.2¢
Change
0.002(6.67%)
Mkt cap ! $28.87M
Open High Low Value Volume
3.1¢ 3.3¢ 3.1¢ $13.79K 424.2K

Buyers (Bids)

No. Vol. Price($)
1 329429 3.2¢
 

Sellers (Offers)

Price($) Vol. No.
3.4¢ 100000 1
View Market Depth
Last trade - 15.51pm 26/07/2024 (20 minute delay) ?
BIT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.